A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).
A Phase 3, Randomized, Parallel-Group, Multi-Center, Multi-National Study for the Evaluation of Efficacy and Safety of (LMW) Heparin/Edoxaban Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis (DVT) and or Pulmonary Embolism (PE).
Evaluation of heparin/edoxaban tosylate (DU176b) versus heparin/warfarin in preventing recurrence of blood clots in patients with acute symptomatic deep-vein blood clots in the legs and/or blood clots in the lungs.
Inclusion Criteria:
Exclusion Criteria:
Randallstown, Virginia, United States
Pcia de Corrientes, Argentina
Saint Leonards NSW, Australia
Westmead NSW, Australia
Sr. M. Restitutagasse, Austria
Hebei Province, China
Jiangsu, China
Sichuan Province, China
Arhus N., Denmark
Ringvej, Denmark
Hetztessy, France
Roskilde, France
Saint Aubin Surscie, France
Maglodi, Hungary
Rakoczi, Hungary
Zrinyi, Hungary
Andhra Pradesh, India
Gujarat, India
Holon, India
Karnataka, India
Kerala, India
Madhya Pradesh, India
Maharashtra, India
Punjab, India
Rajasthan, India
Secunderbad, India
Tamil Nadu, India
Uttar Pradesh, India
Emilia, Italy
Hokkaido, Japan
Hokkaido, Japan
Col. Lomas Altas C.P, Mexico
Monterrey, Nuevo Leon, Mexico
Outram Road, Singapore
Lyttleton, South Africa
Nakhorn Nayok, Thailand
Vinnitsya, Ukraine